GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (OTCPK:TDSGF) » Definitions » FCF Yield %

TDSGF (Telo Genomics) FCF Yield % : -27.27 (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Telo Genomics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Telo Genomics's Trailing 12-Month Free Cash Flow is $-1.65 Mil, and Market Cap is $5.77 Mil. Therefore, Telo Genomics's FCF Yield % for today is -27.27%.

The historical rank and industry rank for Telo Genomics's FCF Yield % or its related term are showing as below:

TDSGF' s FCF Yield % Range Over the Past 10 Years
Min: -38.42   Med: 0   Max: 0
Current: -27.27


TDSGF's FCF Yield % is ranked worse than
79.39% of 228 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.85 vs TDSGF: -27.27

Telo Genomics's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.


Telo Genomics FCF Yield % Historical Data

The historical data trend for Telo Genomics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics FCF Yield % Chart

Telo Genomics Annual Data
Trend Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.87 -4.22 -8.40 -14.39 -15.30

Telo Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.08 -20.39 -29.10 -12.52 -14.72

Competitive Comparison of Telo Genomics's FCF Yield %

For the Diagnostics & Research subindustry, Telo Genomics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telo Genomics's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Telo Genomics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Telo Genomics's FCF Yield % falls into.



Telo Genomics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Telo Genomics's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.798 / 11.754368235
=-15.30%

Telo Genomics's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.345 * 4 / 9.375907425
=-14.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telo Genomics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Telo Genomics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Telo Genomics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Telo Genomics Business Description

Traded in Other Exchanges
Address
101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.